A carregar...

Plasma Rich in Growth Factors for the Treatment of Cicatrizing Conjunctivitis

PURPOSE: The objective was to evaluate the clinical results obtained from the use of immunosafe plasma rich in growth factors (isPRGF) in the treatment of patients with cicatrizing conjunctivitis (CC) who had not responded to the usual therapy. PATIENTS AND METHODS: This is a retrospective study tha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Ophthalmol
Main Authors: de la Sen-Corcuera, Borja, Montero-Iruzubieta, Jesús, Sánchez-Ávila, Ronald M, Orive, Gorka, Anitua, Eduardo, Caro-Magdaleno, Manuel, Merayo-Lloves, Jesús
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7306461/
https://ncbi.nlm.nih.gov/pubmed/32606577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S252253
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!